ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 796

Single Cell Gene Expression Studies in Lupus Patient Monocytes Reveal a Unique Anti-Inflammatory Population of Non-Classical  Monocytes Associated with Clinical Quiescence

Zhongbo Jin1, Wei Fan2,3, Mark A. Jensen4, Jessica M. Dorschner1, Danielle Vsetecka1, Shreyasee Amin5, Ashima Makol6, Floranne C. Ernste7, Thomas Osborn7, Kevin G. Moder5, Vaidehi Chowdhary5 and Timothy B. Niewold1, 1Division of Rheumatology and Department of Immunology, Mayo Clinic, Rochester, MN, 2Department of Rheumatology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, China, Shanghai, China, 3Mayo Clinic, Rochester, MN, 4Divsion of Rheumatology and Department of Immunology, Mayo Clinic, Rochester, MN, 5Rheumatology, Mayo Clinic, Rochester, MN, 6Division of Rheumatology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, 7Division of Rheumatology, Mayo Clinic, Rochester, MN

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: SLE

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Systemic Lupus Erythematosus - Human Etiology and Pathogenesis Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

Our previous gene expression studies in sorted immune cell populations in SLE has shown that different cell types from the same blood sample demonstrate diverse gene expression parameters.  These studies also suggested that heterogeneity in gene expression runs deeper than major immune cell subsets.  In this study, we examine IFN signatures in single monocytes isolated from SLE patients.

Methods:

CD14++CD16– classical monocytes (CLs) and CD14dimCD16+ non-classical monocytes (NCLs) from 14 SLE patients were purified by magnetic separation.  The Fluidigm single cell capture and pre-amplification  System was used for single cell capture and target gene pre-amplification.  Fluidigm Biomark system (Rt-PCR system) was used to quantify expression of 87 monocyte-related genes.  IFN-induced genes in monocytes were identified by culturing monocytes isolated from whole blood of healthy controls with or without IFN-α. Genes significant up-regulated by IFN were identified as IFN-induced genes in current study. Limit of Detection (LOD) of Rt-PCR was set at 28 cycles.  An individual cell IFN score was given based upon the sum of expression of IFN-induced genes. Hierarchical clustering was generated by using Cluster 3.0 and Java Treeview. 

Results: Both CLs and NCLs demonstrated a wide range of expression of IFN-induced genes, and NCL monocytes had higher IFN scores than CL monocytes. Hierarchical clustering of all cells displayed clustering of cells in subsets within the CL and NCL lineages, as well as expression patterns that were shared by both lineages.  We found four gene sets that clustered monocytes functionally.  These included an IFN-induced gene set, two inflammatory gene sets, and one immunosuppressive gene set.  Interestingly, we could define a large subset of NCL monocytes with upregulation of suppressive transcripts (including TGF-β and PDL1) and IFN-induced transcripts were also upregulated, while the two inflammatory gene sets were down-regulated.  These cells were highly over-represented in a patient with inactive disease who was on immunosuppressants at the time of blood draw.  The proportion of anti-inflammatory gene set expressing NCLs was inversely correlated with anti-dsDNA titers (rho = -0.77, p=0.0051) and positively correlated with C3 complement (rho = 0.68, p=0.030) in the SLE patient group, suggesting that these cells are also associated with serological quiescence.  

Conclusion: Using single cell gene expression, we have identified a unique population of NCL monocytes in SLE patients with upregulation of a combination of anti-inflammatory and IFN-induced transcripts.  These cells correspond with clinical and serological quiescence.


Disclosure: Z. Jin, None; W. Fan, None; M. A. Jensen, None; J. M. Dorschner, None; D. Vsetecka, None; S. Amin, None; A. Makol, None; F. C. Ernste, None; T. Osborn, None; K. G. Moder, None; V. Chowdhary, None; T. B. Niewold, None.

To cite this abstract in AMA style:

Jin Z, Fan W, Jensen MA, Dorschner JM, Vsetecka D, Amin S, Makol A, Ernste FC, Osborn T, Moder KG, Chowdhary V, Niewold TB. Single Cell Gene Expression Studies in Lupus Patient Monocytes Reveal a Unique Anti-Inflammatory Population of Non-Classical  Monocytes Associated with Clinical Quiescence [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/single-cell-gene-expression-studies-in-lupus-patient-monocytes-reveal-a-unique-anti-inflammatory-population-of-non-classical-monocytes-associated-with-clinical-quiescence/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/single-cell-gene-expression-studies-in-lupus-patient-monocytes-reveal-a-unique-anti-inflammatory-population-of-non-classical-monocytes-associated-with-clinical-quiescence/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology